Monte Rosa Therapeutics Inc (GLUE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | GLUE | SNDX | RXRX | ||
| Company | Monte Rosa Therapeutics Inc | Syndax Pharma | Recursion Pharmaceuticals Inc Cl A | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 22.57 | 21.20 | 3.62 | ||
| High | 23.22 | 21.77 | 3.74 | ||
| Low | 22.16 | 20.86 | 3.55 | ||
| Latest | 23.01 | 21.78 | 3.65 | ||
| Change | +0.72 | +0.47 | +0.13 | ||
| % Change | +3.23% | +2.21% | +3.69% | ||
| Volume | 401,466 | 1,626,328 | 15,524,182 | ||
| 20-Day Average Volume | 1,494,802 | 2,230,338 | 21,074,697 | ||
| Previous Close | 22.29 | 21.31 | 3.52 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 18.71 | 18.79 | 3.34 | ||
| 20-Day Raw Stochastic | 99.37% | 99.28% | 69.71% | ||
| 20-Day Relative Strength | 69.46 | 60.68 | 58.49 | ||
| Weighted Alpha | +172.25 | +88.17 | -26.56 | ||
| Today's Opinion | 88% Buy | 24% Buy | 24% Sell | ||
| Previous Opinion | 88% Buy | 8% Buy | 24% Sell | ||
| Last Month's Opinion | 80% Buy | 8% Sell | 64% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +24.13% since 06/22/26 | +11.08% since 06/22/26 | +16.66% since 06/22/26 | ||
| Low | 18.38 on 06/23/26 | 19.21 on 06/23/26 | 3.09 on 06/23/26 | ||
| High | 23.22 on 06/29/26 | 21.50 on 06/29/26 | 3.74 on 06/29/26 | ||
| 1-Month | |||||
| %Chg | +17.58% since 05/29/26 | +9.55% since 05/29/26 | +3.34% since 05/29/26 | ||
| Low | 16.11 on 06/08/26 | 16.66 on 06/08/26 | 2.95 on 06/11/26 | ||
| High | 23.22 on 06/29/26 | 21.50 on 06/29/26 | 4.04 on 06/04/26 | ||
| 3-Month | |||||
| %Chg | +50.68% since 03/27/26 | -8.64% since 03/27/26 | +26.18% since 03/27/26 | ||
| Low | 15.28 on 03/30/26 | 16.66 on 06/08/26 | 2.77 on 05/19/26 | ||
| High | 23.22 on 06/29/26 | 25.53 on 04/06/26 | 4.04 on 06/04/26 | ||
| 6-Month | |||||
| %Chg | +43.77% since 12/29/25 | +1.85% since 12/29/25 | -10.17% since 12/29/25 | ||
| Low | 13.69 on 01/06/26 | 16.66 on 06/08/26 | 2.77 on 05/19/26 | ||
| High | 25.77 on 01/08/26 | 25.59 on 03/25/26 | 5.24 on 01/22/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 1,883,037 | 1,888,279 | 1,865,266 | ||
| Shares Outstanding, K | 84,479 | 88,610 | 529,905 | ||
| Annual Sales | 123,670,000 | 172,350,000 | 74,680,000 | ||
| Annual Net Income | -38,630,000 | -285,420,000 | -644,760,000 | ||
| Last Quarter Sales | 4,210,000 | 64,860,000 | 6,470,000 | ||
| Last Quarter Net Income | -44,500,000 | -42,670,000 | -117,500,000 | ||
| 60-Month Beta | 1.60 | 0.38 | 1.04 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.45 on 05/07/26 | -0.48 on 04/30/26 | -0.22 on 05/06/26 | ||
| Earnings Date | 08/06/26 | 08/03/26 | 08/04/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||